Literature DB >> 17895825

Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.

Jeffrey L Bennett, Scott Thomas, Jeffrey L Olson, Naresh Mandava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17895825     DOI： 10.1097/WNO.0b013e31814b273d

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN： 1070-8022            Impact factor:   3.042


× No keyword cloud information.
  19 in total

1.  Effects of L-arginine on anatomical and electrophysiological deterioration of the eye in a rodent model of nonarteritic ischemic optic neuropathy.

Authors:  Hideki Chuman; Tomoyuki Maekubo; Takako Osako; Michitaka Ishiai; Naoko Kawano; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-29       Impact factor: 2.447

2.  Laser speckle flowgraphy for differentiating between nonarteritic ischemic optic neuropathy and anterior optic neuritis.

Authors:  Tomoyuki Maekubo; Hideki Chuman; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-22       Impact factor: 2.447

3.  Management of non-arteritic anterior ischemic optic neuropathy.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 3.117

4.  Effects of steroid administration and transcorneal electrical stimulation on the anatomic and electrophysiologic deterioration of nonarteritic ischemic optic neuropathy in a rodent model.

Authors:  Takako Osako; Hideki Chuman; Tomoyuki Maekubo; Michitaka Ishiai; Naoko Kawano; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2013-05-09       Impact factor: 2.447

5.  A Single Intravitreal Injection of Ranibizumab Provides No Neuroprotection in a Nonhuman Primate Model of Moderate-to-Severe Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Neil R Miller; Mary A Johnson; Theresa Nolan; Yan Guo; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 6.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

7.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

8.  Vasodilatory effects of antivascular endothelium growth factor (VEGF) antibody, corticosteroid, and nitric oxide on the posterior ciliary arteries.

Authors:  Hideki Chuman; Naoko Kawano; Maki Kozawa; Nobuhisa Nao-I
Journal:  Jpn J Ophthalmol       Date:  2012-09-08       Impact factor: 2.447

9.  Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial.

Authors:  D B Rootman; H S Gill; E A Margolin
Journal:  Eye (Lond)       Date:  2013-02-01       Impact factor: 3.775

10.  Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

Authors:  Martin Ganssauge; Helmut Wilhelm; Karl-Ulrich Bartz-Schmidt; Sabine Aisenbrey
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 3.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.